Protective Genes in the Vessel Wall: Modulators of Graft Survival and Function
- 15 July 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 82 (Supplement) , S36-S40
Abstract
Protecting a vascularized graft from transplant arteriosclerosis requires inhibition of host immune effectors, but protective responses emanating from the graft aimed at maintaining/restoring "homeostasis" might be equally important. Expression of the "protective" genes A20, heme-oxygenase-1 (HO-1), Bcl-xL, inducible nitric oxide synthase (iNOS), and others in the vessel wall of rodent allografts and xenografts correlates with absence of transplant arteriosclerosis. Given the antiapoptotic and anti-inflammatory functions of these genes in endothelial cells and their anti-inflammatory/antiproliferative and sometimes proapoptotic function in neointimal smooth muscle cells, we hypothesize that their expression survives to limit graft injury by maintaining vascular integrity, controlling inflammation and promoting healing. Beyond this beneficial effect, their expression in the vessel wall may also positively impact the alloimmune response.Keywords
This publication has 28 references indexed in Scilit:
- A20 protects endothelial cells from TNF-, Fas-, and NK-mediated cell death by inhibiting caspase 8 activationBlood, 2004
- Heme oxygenase‐1‐derived carbon monoxide protects hearts from transplant‐associated ischemia reperfusion injuryThe FASEB Journal, 2004
- A20 Protects From CD40-CD40 Ligand-Mediated Endothelial Cell Activation and ApoptosisCirculation, 2003
- Endothelial Progenitor Cells Are Decreased in Blood of Cardiac Allograft Patients With Vasculopathy and Endothelial Cells of Noncardiac Origin Are Enriched in Transplant AtherosclerosisCirculation, 2003
- Expression of A20 in the vessel wall of rat-kidney allografts correlates with protection from transplant arteriosclerosisTransplantation, 2003
- Chronic RejectionImmunity, 2001
- Cardiac allograft vasculopathyCurrent Opinion in Cardiology, 2000
- Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-κBJournal of Clinical Investigation, 1999
- A20 Blocks Endothelial Cell Activation through a NF-κB-dependent MechanismJournal of Biological Chemistry, 1996
- BOTH ALLOANTIGEN-DEPENDENT AND -INDEPENDENT FACTORS INFLUENCE CHRONIC ALLOGRAFT REJECTIONTransplantation, 1995